the aid library

Filter

5349

Technical Note on Education During the COVID-19 Pandemic

Inter-agency Network for Education in Emergencies (2020) CC

This is the first version of the INEE technical guideline to support education during the Covid-19 pandemic. It is a living document that will be regularly updated to meet the learning and well-being needs of children, adolescents, youth, teachers, caregivers and other education personnel affected b ... more

Cordaid, Social Entrepreneurship and Catholic Social Thought

Grotenhuis, R. Cordaid (2015) C1

Strategic Advice

Antigen-detection in the diagnosis of SARS-CoV-2 infection
recommended

World Health Organization WHO (2021) C_WHO

Interim guidance, 6 October 2021 Direct detection of SARS-CoV-2 viral proteins (antigens) in nasal swabs and other respiratory secretions using lateral flow immunoassays (also known as rapid diagnostic tests, RDTs) offers a faster and less expensive method to test for SARS-CoV-2 than the reference ... more

Protect the Progress: Rise, Refocus, Recover - 2020 Progress Report on the Every Woman Every Child Global Strategy for Women’s, Children’s and Adolescents’ Health (2016–2030)

UNICEF, World Health Organisation (2020) C_WHO

Conflict, climate crisis and COVID-19 pose great threats to the health of women and children.

Post-acute COVID-19 syndrome

Nalbandian, A.; et al. (2021) CC

Nature Medicine, https://doi.org/10.1038/s41591-021-01283-z

Ten facts about land systems for sustainability

Meyfroidt, P.; et al. (2022) CC

PNAS 2022 Vol. 119 No. 7 e2109217118

2021 Antibacterial agents in clinical and preclinical development: an overview and analysis

World Health Organization WHO (2022) C_WHO

This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent ... more

Climate Change and Chagas Disease in the americas: A qualitative systematic review

Graves B.N. (2019) C2

Chagas disease is currently endemic and also predicted to be at increased transmission risk under future climate change scenarios. Similarly, an expansion of areas in the United States at increased risk for Chagas disease transmission is also expected over the next several decades under climate chan ... more

Core components, concepts and strategies for parasitic and vector-borne disease elimination with afocus on schistosomiasis: A landscape analysis

Monnier, N.; IT. Barth-Jaegg, S. Knopp, (2020) CC

PLoS Negl TropDis14(10): e0008837. https://doi.org/ 10.1371/journal.pntd.0008837. We conducted alandscape analysis on parasitic and vector-borne disease elimination approaches with the aim toidentify evidence-based strategies, core components and key concepts for achieving and sustaining schistosom ... more

Myanmar’s National Adaptation Programme of Action (NAPA) to Climate Change

The Republic of the Union of Myanmar, Ministry of Environmental Conservation and Forestry, National Environmental Conservation Committee (2012) C1

Sectors in which Priority Adaptation Projects should be implemented first include:
- 1) Agriculture, Early Warning Systems and Forest (First Priority Level Sectors). This is followed by:
- 2) Public Health and Water Resources (Second Priority Level Sectors);
- 3) Coastal Zone (Thir ... more

Promoting access to medical technologies and innovation, second edition, 30 August 2021

World Health Organization WHO and World Intellectual Property Organization WTO, WHO, WIPO (2021) CC

The second edition of the joint WHO, WIPO and WTO publication “Promoting Access to Medical Technologies and Innovation: Intersections between public health, intellectual property and trade” (the Trilateral Study),* published in 2020, included a special insert mappi ... more

Medical device donations: considerations for solicitation and provision. Second edition

World Health Organization WHO (2024) CC

Medical devices are used for the prevention, diagnosis and treatment of illness and diseases and for rehabilitation. WHO developed guidance on medical device donation in 2011, which has been now reviewed, with new evidence, new references on considerations for medical device solicitation and provisi ... more

Gender in Humanitarian Aid: Different Needs, Adapted Assistance

European Commission (2013)

Malawi national action plan on antimicrobial resistance: review of progress in the human health sector

World Health Organization WHO (2022) C_WHO

This policy brief aims to provide a review of the current progress on implementing the Malawi national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing a ... more

Pediatrics Clinical treatment guidelines

Ministry of Health, Rwanda (2012)

The Livelihood and Poverty Mapping Analysis at Regional Level in Pakistan

Begum, Shazia Wageningen University and Research Centre (2015) C1

An attempt has been made to map the incidence of uni-dimensional and multi-dimensional poverty simultaneously arguably for the first time in Pakistan. While multi-dimensional poverty map is calculated using PSLM 2010-11; small area estimation technique is utilized to map uni-dimensional poverty usin ... more

Screening for cardiovascular disease risk and subsequent management in low and middle income countries: challenges and opportunities

Bovet, P.; Chiolero, A.; Paccaud, F. et al. Public Health Reviews (2015) CC

Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the leading cause of premature mortality in low and middle income countries (LMICs). Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector ... al population-based interventions to reduce CVD risk factors in the entire population. Methods: We describe key public health considerations in identifying and managing individuals at high risk of CVD in LMICs. Results: A main objective of any strategy to identify individuals at high CVD risk is to maximize the number of CVD events averted while minimizing the numbers of individuals needing treatment. Scores estimating the total risk of CVD (e.g. ten-year risk of fatal and non-fatal CVD) are available for LMICs, and are based on the main CVD risk factors (history of CVD, age, sex, tobacco use, blood pressure, blood cholesterol and diabetes status). Opportunistic screening of CVD risk factors enables identification of persons with high CVD risk, but this strategy can be widely applied in low resource settings only if cost effective interventions are used (e.g. the WHO Package of Essential NCD interventions for primary health care in low resource settings package) and if treatment (generally for years) can be sustained, including continued availability ofaffordable medications and funding mechanisms that allow people to purchase medications without impoverishing them (e.g. universal access to health care). Thisalso emphasises the need to re-orient health systems in LMICs towards chronic diseases management. Conclusion: The large burden of CVD in LMICs and the fact that persons with high CVD can be identified and managed along cost-effective interventions mean that health systems need to be structured in a way that encourages patient registration, opportunistic screening of CVD risk factors, efficient procedures for the management of chronic conditions (e.g. task sharing) and provision of affordable treatment for those with high CVD risk. The focus needs to be in primary care because that is where most of the population can access health care and because CVD programmes can be run effectively at this level. more

Developmental Disabilities

Institute of Medicine (US); Committee on Nervous System Disorders in Developing Countries; National Academy of Sciences (2001) C2

Neurological, Psychiatric, and Developmental Disorders: Meeting the Challenge in the Developing World Institute of Medicine (US) Committee on Nervous System Disorders in Developing Countries. Washington (DC): National Academies Press (US); 2001.

Formulary of Narcotic Drugs and Psychotropic Substances for Ethiopia

Drug Administration and Control Authority (DACA) of Ethiopia (2004) C1

Guidelines for laboratory and field testing of molluscicides for control of schistosomiasis

World Health Organization World Health Organization WHO (2019) C_WHO

This document provides up-to-date guidance on laboratory studies as well as smallscale (semi-field) and large-scale field trials to assess the efficacy and determine field application rates of new molluscicide products for control of schistosomiasis.